| biotyping of serratia marcescens and its use in epidemiological studies. | a serratia marcescens biotyping system using eight carbon sources (benzoate, dl-carnitine, m-erythritol, 3-hydroxybenzoate, 4-hydroxybenzoate, lactose, d-quinate, and trigonelline), a tetrathionate reduction test, production of prodigiosin, and horse blood hemolysis was derived from a recent numerical taxonomic study (grimont et al., j. gen. microbiol. 98:39-66, 1977). a total of 98.6% of 2,210 isolates from various sources could be assigned to 1 of 19 biotypes. distribution and spread of 1,088 ... | 1978 | 353073 |
| extended-spectrum beta-lactamase-producing enterobacteriaceae in community and private health care centers. | in 1999, 39 of 2,599 isolates of the family enterobacteriaceae (1.5%) collected by eight private laboratories in the aquitaine region in france produced an extended-spectrum beta-lactamase (esbl). among these were 19 enterobacter aerogenes isolates; 8 klebsiella pneumoniae isolates; 6 escherichia coli isolates; 3 proteus mirabilis isolates; and 1 isolate each of serratia marcescens, morganella morganii, and providencia stuartii. esbl producers were isolated from 38 patients, including 33 residen ... | 2003 | 14576109 |